Science Explorer Back to mapMap
Discussion
Researcher · ImmunoGen (United States) · United States

Jose F. Ponte

Jose F. Ponte publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research and Synthesis and pharmacology of benzodiazepine derivatives.

OpenAlex
World rank
#1,196,475
of 7,710,434 ranked researchers
Rank in United States
#383,871
of 1,627,098
Works
77
Citations
2.7k
Citations per work
34.8
h-index
20
i10-index 26Top 23% in Oncology
Jose F. Ponte

What does Jose F. Ponte research?

Jose F. Ponte's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (14%), Chemistry (6%).

Health Sciences: 39 works · 51.0% of their workMedicine: 39 works · 51.0% of their workOncology: 23 works · 30.1% of their workRadiology, Nuclear Medicine and Imaging: 13 works · 17.0% of their workPulmonary and Respiratory Medicine: 3 works · 3.9% of their workEverything else: 17 works · 22.2% of their workLife Sciences: 16 works · 20.3% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 14.4% of their workMolecular Biology: 11 works · 14.4% of their workImmunology and Microbiology: 5 works · 5.9% of their workImmunology: 5 works · 5.9% of their workPhysical Sciences: 5 works · 6.5% of their workChemistry: 5 works · 6.5% of their workOrganic Chemistry: 5 works · 6.5% of their workTHEIR WORKJose F. Ponte77works
Life Sciences20%Physical Sciences6%Health Sciences51%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3951.0%
  2. Everything else1722.2%
    1. Biochemistry, Genetics and Molecular Biology1114.4%
    2. Immunology and Microbiology55.9%
    1. Chemistry56.5%
  1. 1Oncology30% of their works
  2. 2Radiology, Nuclear Medicine and Imaging17% of their works
  3. 3Molecular Biology14% of their works
  4. 4Organic Chemistry6% of their works
  5. 5Immunology6% of their works
  6. 6Pulmonary and Respiratory Medicine4% of their works

Research topics

Which keywords describe Jose F. Ponte's research?

The keywords of their largest research topics: Breast Cancer, Chemotherapy, HER2, Trastuzumab, Fc Receptors, Therapeutic Antibodies, Biological Evaluation and Synthesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Breast Cancer372 topics
  2. Chemotherapy372 topics
  3. HER2321 topic
  4. Trastuzumab321 topic
  5. Fc Receptors201 topic
  6. Therapeutic Antibodies201 topic
  7. Biological Evaluation102 topics
  8. Synthesis102 topics
  9. DNA-Interactive Agents61 topic
  10. Pyrrolobenzodiazepines61 topic
  11. CDK4/6 Inhibitors51 topic
  12. DNA Methylation51 topic
  13. Genomic Analysis51 topic
  14. Histone Modification51 topic
  15. Ovarian Cancer51 topic
  16. PET Imaging51 topic
  17. Palbociclib51 topic
  18. Radiopharmaceuticals51 topic
  19. Antimicrobial Activity41 topic
  20. Quinoxaline41 topic

Where does Jose F. Ponte work?

Jose F. Ponte's main affiliation in the publication record is ImmunoGen (United States), United States.

How many publications and citations does Jose F. Ponte have?

OpenAlex counts 77 works and 2,680 citations for Jose F. Ponte, an h-index of 20, ranking #1,196,475 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jose F. Ponte. Posts are plain text and can be reported.